Government to push up with re-assessment plan over 3,000 drugs

Published: 2009-01-28 06:59:00

Updated: 2009-01-28 06:59:00

The government has reaffirmed that it will re-evaluate the economic effectiveness of 3,000 medicines listed in national health insurance this year without any modification, rejecting the speculation that the re-assessment schedule would be delayed in the midst of contracted business conditions.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK